Your partner for Dx compliance in translational research

webinar

How digital regulatory tools can accelerate your clinical performance study

by Joseph Morgan

Between 33,000 and 42,200 European patients are expected to experience delayed access to clinical trials over the next 3 years as a result of IVDR.

Join us and learn how ARCs experts, supported by our digital regulatory navigation tools, can accelerate your clinical performance study approval.

What you’ll learn:

  • How the regulatory landscape has changed in key geographic markets and how it impacts device study approvals.
  • How to minimise the impact of IVDR on your precision medicine trials.
  • Strategies to expedite patient screening and keeping your clinical development programmes on track
  • Spotlight on ARC360, your online regulatory navigator to save you valuable time and resources.

Joseph Morgan
Article written by Joseph Morgan
October 24, 2023
After graduating from Ulster University with a Bachelors of Science in Business Studies with Marketing Joseph joined J&K Coaches as a Sales and Marketing Assistant before taking a role at PwC where he provided legal consulting for blue chip cl...
After graduating from Ulster University with a Bachelors of Science in Business Studies with Marketing Joseph joined J&K Coaches as a Sales and Marketing Assistant before taking a role at PwC where he provided legal consulting for blue chip clientele such as Investment banks, E-Commerce and Energy companies. During his time at PwC Joseph also gained valuable marketing experience working with both senior internal and external stakeholders developing products to fit clients’ needs. Joseph also puts his marketing expertise to use for his local community, specifically amateur theatre groups. Outside of work, Joseph is a gym regular who loves to travel and enjoys spending time with his three dogs, taking them on adventures.
CTA

Get in touch with our expert team today